We are live on
!
Find out more
FA
Forefront Analytics Portfolio holdings
AUM
$110M
1-Year Est. Return
18.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$16.1M
(+7.5%)
Cap. Flow
-$1.11M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
52.93%
Holding
64
New
7
Increased
26
Reduced
25
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23M |
| 2 |
RPAR Risk Parity ETF
RPAR
|
+$806K |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$553K |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$532K |
| 5 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$437K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$1.41M |
| 2 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$1.14M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$867K |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$846K |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$746K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.89% |
| 2 | Healthcare | 0.87% |
| 3 | Financials | 0.8% |
| 4 | Industrials | 0.15% |
| 5 | Real Estate | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$4.9T
| $235K | 0.1% |
1,766
-1,968
| -53% | -$237K |
|
52
Vanguard Total World Stock ETF
VT
$76.6B
| $223K | 0.1% |
+2,407
| New | +$209K |
|
53
CVS Health
CVS
$137B
| $220K | 0.1% |
+3,234
| New | +$210K |
|
54
Henry Schein
HSIC
$10B
| $220K | 0.1% |
+3,274
| New | +$211K |
|
55
Danaher
DHR
$144B
| $206K | 0.09% |
1,045
-99
| -9% | -$19.8K |
|
|
ORTX
56
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $139K | 0.06% |
3,209
+172
| +6% | +$7.7K |
|
57
Dyadic International
DYAI
$45.9M
| $124K | 0.05% |
23,416
+735
| +3% | +$4.83K |
|
|
VXRT
58
DELISTED
Vaxart
VXRT
| $106K | 0.05% |
+18,250
| New | +$116K |
|
59
Geron
GERN
$924M
| $97K | 0.04% |
60,175
-3,755
| -6% | -$6.84K |
|
|
RVLP
60
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $72K | 0.03% |
18,091
-2,564
| -12% | -$14.8K |
|
|
DVAX
61
DELISTED
Dynavax Technologies
DVAX
| $58K | 0.03% |
13,072
-4,130
| -24% | -$18.7K |
|
|
ADAM
62
Adamas Trust
ADAM
$807M
| $37K | 0.02% |
2,500
| – | – |
|
|
PEI
63
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $10K | ﹤0.01% |
667
| – | – |
|
64
BioNTech
BNTX
$23.1B
| – | – |
-3,274
| Closed | -$224K |
|
Similar funds
NC
PXPO
OWA
MCM
AC
NA
NMC
BCM
Forefront Analytics's Q4 2020 Portfolio in Review
As of Q4 2020, Forefront Analytics held 64 positions worth $230M, up 7.5% from $214M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Forefront Analytics's Q4 2020 filing shows 7 new, 26 increased, 25 reduced and 1 closed positions. Its largest new stake was RPAR Risk Parity ETF: 35,301 shares worth $845K. The largest sale was Vanguard World Funds Extended Duration ETF, an estimated $1.41M.
By sector, the portfolio is most concentrated in Technology at 0.89% of assets, up from 0.85% a quarter earlier, followed by Healthcare and Financials.
- Forefront Analytics's largest Q4 2020 buy was RPAR Risk Parity ETF: 35,301 shares worth $845K.
- Forefront Analytics added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.23M increase.
- Forefront Analytics's biggest Q4 2020 reduction was Vanguard World Funds Extended Duration ETF, cutting an estimated $1.41M.
- Forefront Analytics fully exited BioNTech in Q4 2020, selling an estimated $224K.
- Forefront Analytics's ten largest holdings make up 53% of its $230M portfolio in Q4 2020.
- Forefront Analytics opened 7 new positions and closed 1 in Q4 2020.
- Forefront Analytics's portfolio value rose 7.5% quarter-over-quarter to $230M.
Based on Forefront Analytics's 13F filing for Q4 2020, filed 12 Feb 2021.